Elizabeth was diagnosed in late December 2020 with an aggressive, high-grade form of non-Hodgkin B-cell lymphoma (HGBCL, triple expression, atypical double-hit - MYC amplification with BCL2 translocation, Ki67 > 80%). She underwent 6 cycles of DA-R-EPOCH (up to dose level 4) and achieved a complete metabolic response in late July 2021.
We will be updating less often now that her treatment has completed, but will still update ASAP with any news we receive. Thank you for visiting.
